Document is current
Any future updates will be listed below
-
Authors
Leegwater, Emiel http://orcid.org/0000-0001-5062-977X
Dol, Lisa
Benard, Menno R.
Roelofsen, Eveline E.
Delfos, Nathalie M.
van der Feltz, Machteld
Mollema, Femke P. N.
Bosma, Liesbeth B. E.
Visser, Loes E.
Ottens, Thomas H.
van Burgel, Nathalie D.
Arbous, Sesmu M.
El Bouazzaoui, Lahssan H.
Knevel, Rachel
Groenwold, Rolf H. H.
de Boer, Mark G. J.
Visser, Leo G.
Rosendaal, Frits R.
Wilms, Erik B.
van Nieuwkoop, Cees
-
Funding
Funding for this research was provided by:
Gilead Sciences
- License Information
-
More Information
Article History
Received: 17 July 2023
Accepted: 13 September 2023
First Online: 6 October 2023
Declarations
:
: Emiel Leegwater and Erik B Wilms of The Hague Hospital Pharmacy received an unrestricted research grant from Gilead Sciences Inc. T.H.O. participated in a COVID-19 Digital Advisory Board from Gilead Sciences Inc. Lisa Dol, Menno R Benard, Eveline E Roelofsen, Nathalie M Delfos, Machteld van der Feltz, Femke PN Mollema, Liesbeth BE Bosma, Loes E Visser, Thomas H Ottens, Nathalie D van Burgel, Sesmu M Arbous, Lahssan H El Bouazzaoui, Rachel Knevel, Rolf HH Groenwold, Mark GJ de Boer, Leo G Visser, Frits R Rosendaal, and Cees van Nieuwkoop have nothing to disclose.
: The study was conducted in compliance with the Declaration of Helsinki and was approved by the COVID-19 Scientific and Ethics Committee for observational studies of the Leiden University Medical Centre and local scientific boards of the participating hospitals.
